Hassan Maleki | Bio materials | Best Researcher Award

Assist. Prof. Dr. Hassan Maleki | Bio Materials | Best Researcher Award

Medical Nanotechnology at Kermanshah University of Medical Sciences | Iran

Dr. Hassan Maleki is a distinguished researcher and faculty member at the Department of Medical Nanotechnology, School of Pharmacy, Kermanshah University of Medical Sciences. His academic journey in nanomedicine began with a Bachelor’s and Master’s in Operating Room and Medical Nanotechnology from Tehran University of Medical Sciences, followed by a Ph.D. in Medical Nanotechnology from the same institution. Dr. Maleki’s scientific contributions span across nanomedicine, biomaterials, regenerative medicine, and targeted drug delivery, reflected through his extensive publication record in high-impact journals. His works include studies such as Preparation of Imatinib Base Loaded Human Serum Albumin for Application in the Treatment of Glioblastoma, Methotrexate-Loaded PLGA Nanoparticles: Preparation, Characterization and Cytotoxicity on Human Glioblastoma Cells, Paclitaxel and Etoposide Co-Loaded mPEG-PLGA Nanoparticles: Artificial Neural Network Investigation, Effect of Paclitaxel/Etoposide Co-Loaded Polymeric Nanoparticles on Tumor Size and Survival Rate in Glioblastoma, Encapsulation of Ginger Extract in Nanoemulsions: Preparation, Characterization and in vivo Evaluation in Rheumatoid Arthritis, Nanofiber-Based Systems Against Skin Cancers: Therapeutic and Protective Approaches, Achillea Wilhelmsii–Incorporated Chitosan@Eudragit Nanoparticles for Enhanced Ulcerative Colitis Treatment, Nanotechnology-Mediated Precision Drug Delivery Strategies for Breast Cancer Treatment, Biofabricated Hydrogel Composite of Tragacanth Gum and Chitosan Loaded with Copper Oxide Nanoparticles for Enhanced Cutaneous Wound Regeneration, Evaluating the Anti-Neuropathic Effects of Naringin-Loaded Chitosan Nanocarriers in a Murine Model, and Development of 5-Fluorouracil/Etoposide Co-Loaded Electrospun Nanofibrous Scaffold for Localized Anti-Melanoma Therapy. His research leadership extends to supervising numerous graduate theses on nanofibrous dressings, hydrogels, nanoemulsions, and liposomal systems for cancer, diabetes, neurodegeneration, and wound healing. Recognized for ranking first nationwide in multiple nanotechnology competitions and exams, Dr. Maleki continues to advance interdisciplinary frontiers of nanotechnology-enabled drug delivery, biomaterial engineering, and cancer nanotherapeutics, earning recognition as one of the leading voices in translational medical nanotechnology research.

Profile: Scopus | Orcid | Google Scholar

Featured Publications:

Khoshnevisan, K., Maleki, H., Samadian, H., Shahsavari, S., Sarrafzadeh, M. H., Larijani, B., & Khorramizadeh, M. R. (2018). Cellulose acetate electrospun nanofibers for drug delivery systems: Applications and recent advances. Carbohydrate Polymers, 198, 131–141.

Samadian, H., Maleki, H., Allahyari, Z., & Jaymand, M. (2020). Natural polymers-based light-induced hydrogels: Promising biomaterials for biomedical applications. Coordination Chemistry Reviews, 420, 213432.

Khoshnevisan, K., Maleki, H., Samadian, H., Doostan, M., & Khorramizadeh, M. R. (2019). Antibacterial and antioxidant assessment of cellulose acetate/polycaprolactone nanofibrous mats impregnated with propolis. International Journal of Biological Macromolecules, 140, 1260–1268.

Samadian, H., Maleki, H., Fathollahi, A., Salehi, M., Gholizadeh, S., Derakhshankhah, H., & Jaymand, M. (2020). Naturally occurring biological macromolecules-based hydrogels: Potential biomaterials for peripheral nerve regeneration. International Journal of Biological Macromolecules, 154, 795–817.

Khoshnevisan, K., Maleki, H., Honarvarfard, E., Baharifar, H., Gholami, M., Faridbod, F., Larijani, B., & Khorramizadeh, M. R. (2019). Nanomaterial based electrochemical sensing of the biomarker serotonin: A comprehensive review. Microchimica Acta, 186(1), 49.

Hui Xiong | Bio Materials | Best Researcher Award

Dr. Hui Xiong | Bio Materials | Best Researcher Award

Associate Professor | China Pharmaceutical University | China

Dr. Hui Xiong is an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University. Her work bridges pharmaceutics, tumor biology, and nanomedicine engineering to create advanced drug delivery systems that improve cancer treatment outcomes. SCI-indexed publications as first or corresponding author, her research contributions have been featured in high-impact journals such as ACS Nano, Nano Letters, Journal of Controlled Release, Small, and Advanced Healthcare Materials. She holds an H-index of 16, four national invention patents, and has secured multiple research grants from the National Natural Science Foundation of China and other prestigious programs. Dr. Xiong’s research emphasizes multifunctional nanocarriers, targeted therapy, tumor microenvironment modulation, and ferroptosis-inducing strategies, particularly for breast cancer. Her translational approach seeks to bridge laboratory innovation with clinical applications, offering new therapeutic paradigms in oncology. Through her leadership and contributions, she has established herself as a rising scholar in nanomedicine-driven pharmaceutics.

Professional Profile

Scopus

Education

Dr. Hui Xiong obtained her Ph.D. in Pharmaceutics from China Pharmaceutical University, one of the leading institutions for pharmaceutical sciences in China. During her doctoral studies, she specialized in advanced drug delivery systems, focusing on the design of multifunctional nanocarriers to overcome therapeutic limitations in cancer treatment. Her doctoral research introduced novel hydroxyapatite-based dual-targeted nanoparticles that enhanced the efficacy of chemotherapeutic drugs, laying the foundation for her later work on multifunctional nanoplatforms. Her training combined pharmaceutics, materials science, and tumor biology, allowing her to integrate multidisciplinary strategies for addressing challenges such as poor bioavailability, tumor heterogeneity, and drug resistance. Following her doctoral training, she expanded her expertise by engaging in postdoctoral projects supported by national and provincial research programs. This educational foundation not only provided her with strong theoretical and technical skills but also shaped her research trajectory toward translational nanomedicine and oncology-focused pharmaceutics.

Experience

Dr. Hui Xiong currently serves as an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University. She has established an independent research program focusing on cancer-targeted nanomedicine and innovative drug delivery platforms. Over the years, she has published extensively in top-tier journals, including ACS Nano, Nano Letters, and Journal of Controlled Release. She has successfully led multiple projects funded by the National Natural Science Foundation of China, China Postdoctoral Science Foundation, and Jiangsu Provincial Research Grants. Beyond publishing Dr. Xiong has also filed and secured four national invention patents, underscoring her commitment to both academic advancement and practical innovation. She is recognized for her work in creating rationally designed drug carriers that integrate features such as stimuli-responsiveness, tumor microenvironment modulation, and combination therapy strategies. Through her academic and research positions, Dr. Xiong has cultivated expertise that translates pharmaceutics research into clinically applicable cancer therapies.

Research Focus

Dr. Hui Xiong’s research is centered on the rational design and development of advanced nanomedicine platforms for cancer therapy. Her work integrates pharmaceutics, materials science, and tumor biology to address major limitations of traditional chemotherapy, including poor bioavailability, drug resistance, and systemic toxicity. She focuses on designing multifunctional and stimuli-responsive nanocarriers capable of precise targeting, controlled release, and tumor microenvironment remodeling. Key directions of her research include pH-activated antiangiogenic therapies, ferroptosis-inducing nanodrugs, vascular normalization strategies, and immune modulation approaches. Her translational research emphasizes applications in breast cancer and pancreatic cancer, where innovative nanoplatforms have demonstrated improved therapeutic indices and synergistic combination effects. Recent studies include self-assembled nano-activators for ferroptosis-immunotherapy, redox-regulated nanodrugs, and bioengineered nanospores targeting tumor-associated macrophages. Ultimately, her research goal is to transform laboratory discoveries into clinically relevant therapies that enhance the precision, safety, and efficacy of oncology treatments, paving the way for next-generation pharmaceutics innovations.

Awards and Honors

Throughout her academic career, Dr. Hui Xiong has received numerous recognitions for her contributions to pharmaceutics and nanomedicine. She has been awarded prestigious funding programs, including the National Natural Science Foundation of China Youth Program, the China Postdoctoral Science Foundation, the China Postdoctoral Science Foundation Special Grant, and the Jiangsu Provincial Postdoctoral Research Grant. These awards highlight her scientific achievements and the national recognition of her research potential. In addition to grant support, her publications have earned attention in high-impact journals, with one study featured on the front cover of Advanced Healthcare Materials. Her H-index and total journal impact factor exceeding reflect her influence in the scientific community. Holding four national patents further emphasizes her contribution to pharmaceutical innovation. These honors collectively demonstrate her success in both academic research and translational innovation, positioning her as an influential figure in the field of pharmaceutics-driven cancer nanomedicine.

Publication Top Notes

Engineering Magnesium Oxide as a Mitochondrial Electron Transport Chain Inhibitor for Enhanced Photodynamic Therapy in Triple-Negative Breast Cancer

Year: 2025

Mitochondria-Targeted Ferroptosis Nanodrug for Triple-Negative Breast Cancer Therapy via Fatty Acid Metabolism Remodeling and Tumor Bacterial Symbiosis Inhibition

Year: 2025

Nanocoated bacteria with H2S generation-triggered self-amplified photothermal and photodynamic effect for breast cancer therapy

Year: 2025
Citation: 2

Conclusion

Dr. Hui Xiong’s impressive research experience, publication record, innovative research, and significant funding make her a strong candidate for the Best Researcher Award. With some additional interdisciplinary collaboration, global impact, and translational research, she could further solidify her position as a leading researcher in her field.

Deborah Lee | Bio Materials | Best Researcher Award

Dr. Deborah Lee | Bio Materials | Best Researcher Award

Assistant Professor | University of Michigan | United States

This individual is an accomplished Critical Care Nurse Practitioner, educator, and healthcare leader with nearly three decades of experience in critical care nursing, emergency medicine, rapid response, and advanced practice. Beginning their career in the coronary care unit, they advanced through supervisory and clinical management roles before transitioning to advanced practice in critical care. Their expertise spans patient management in high-acuity settings, invasive procedures, palliative care, and simulation-based education. At the University of Michigan, they serve as Clinical Assistant Professor and Director of the Clinical Learning Center, where they advance pedagogy in simulation and prepare future nurse practitioners. They also practice as a Critical Care Nurse Practitioner at Henry Ford Health System. Their leadership has influenced rapid response programs, sepsis protocols, simulation training, and interdisciplinary education. With a career blending clinical excellence, innovation, and teaching, they continue to shape both patient outcomes and the next generation of critical care clinicians.

Professional Profile

Scopus

Education

This individual is an accomplished Critical Care Nurse Practitioner, educator, and healthcare leader with nearly three decades of experience in critical care nursing, emergency medicine, rapid response, and advanced practice. Beginning their career in the coronary care unit, they advanced through supervisory and clinical management roles before transitioning to advanced practice in critical care. Their expertise spans patient management in high-acuity settings, invasive procedures, palliative care, and simulation-based education. At the University of Michigan, they serve as Clinical Assistant Professor and Director of the Clinical Learning Center, where they advance pedagogy in simulation and prepare future nurse practitioners. They also practice as a Critical Care Nurse Practitioner at Henry Ford Health System. Their leadership has influenced rapid response programs, sepsis protocols, simulation training, and interdisciplinary education. With a career blending clinical excellence, innovation, and teaching, they continue to shape both patient outcomes and the next generation of critical care clinicians.

Experience

The foundation of this professional’s career is built upon comprehensive education in nursing and advanced practice. After completing initial nursing training and gaining clinical expertise in critical care and emergency nursing, they advanced to graduate-level education as an Adult Gerontology Acute Care Nurse Practitioner (AG-ACNP). Their academic training emphasized pathophysiology, pharmacology, critical care management, and advanced procedures such as intubation and central line insertion. In addition to clinical preparation, their education included curriculum design, clinical instruction, and simulation pedagogy, which later informed their faculty role at the University of Michigan School of Nursing. Their advanced academic preparation has allowed them to function across multiple domains—direct patient care, clinical leadership, palliative care consultation, and academic teaching. Their commitment to lifelong learning is demonstrated by continuous certification in life support programs such as ACLS, PALS, and BLS, and by staying engaged in evidence-based practice, ensuring their knowledge translates to both patient care and student learning.

Research Focus

This professional’s research interests center on critical care nursing, rapid response systems, and simulation-based education. In clinical research, they have focused on the optimization of rapid response protocols, sepsis recognition tools, and early-warning vital sign systems to reduce in-hospital cardiac arrests and improve survival outcomes. Their work also explores palliative care integration into critical care, emphasizing quality of life, symptom management, and transitions to hospice or rehabilitation. In nursing education, they are committed to advancing simulation pedagogy, including psychological safety, scenario development, and the integration of simulation across graduate nursing curricula. As Director of the Clinical Learning Center, they lead initiatives to evaluate the impact of simulation training on clinical readiness, interprofessional teamwork, and patient outcomes. Their scholarship bridges practice and education, reflecting a dual focus on improving both bedside care and the preparation of future advanced practice nurses for complex, high-acuity healthcare environments.

Awards and Honors

Healthcare experience, this professional has held diverse roles spanning clinical, administrative, and academic settings. They began in the coronary care and emergency departments at Hillsdale Community Health Center, advancing to supervisory and clinical management roles. From onward, they served in high-acuity environments at Bronson Methodist Hospital, including the Rapid Response Team, later directing the multidisciplinary rapid response program at Borgess Medical Center. Their advanced practice career includes critical care nurse practitioner roles at Borgess Medical Center, University of Michigan Health System, and most recently, Henry Ford Health System. Alongside clinical practice, they have built an academic career at the University of Michigan School of Nursing, first as Clinical Instructor and later as Clinical Assistant Professor, where they teach and mentor advanced practice nursing students. As Director of the Clinical Learning Center, they oversee simulation pedagogy, faculty development, and accreditation, bridging practice and education seamlessly.

Publication Top Notes

Conclusion

The researcher demonstrates a strong clinical, leadership, teaching, and administrative profile, with a focus on critical care and nurse practitioner education. Their expertise in patient care, leadership, and education make them a strong candidate for the Best Researcher Award. With further research publications, research funding, and interdisciplinary collaboration, they could become an even stronger candidate for this award. Their contributions to the field of nursing and healthcare, and their potential for future research, make them a strong contender for this award.

Ashok Kumar Pandurangan | Tissue Engineering | Excellence in Research

Dr. Ashok Kumar Pandurangan | Tissue Engineering | Excellence in Research

Associate Professor | B.S. Abdur Rahman Crescent Institute of Science and Technology | India

Dr. Ashok Kumar Pandurangan is an accomplished biochemist and cancer researcher with over a decade of academic and research experience across India, the United States, and Malaysia. He is currently serving as an Associate Professor in the School of Life Sciences at B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, since . His expertise lies in molecular oncology, particularly focusing on colon and breast cancers, ulcerative colitis, and cancer therapeutics. His career is marked by significant contributions to drug development, screening methods, and the exploration of natural products in cancer prevention and treatment. With post-doctoral research experience at prestigious institutions such as Children’s Hospital Oakland Research Institute (USA), Universiti Putra Malaysia, and the University of Malaya, he has developed strong international collaborations and research credentials. Passionate about innovation, he continues to integrate fundamental cancer biology with translational approaches aimed at discovering novel and effective therapeutic strategies.

Professional Profile

Scholar

Education

Dr. Ashok Kumar Pandurangan holds a strong academic background in biochemistry, marked by excellence in both coursework and research. He began his academic journey with a B.Sc. in Biochemistry followed by an M.Sc. in Biochemistry  at Islamiah College, affiliated with the University of Madras, where he graduated with distinctions. He then pursued an M.Phil. in Biochemistry at the University of Madras. His passion for cancer biology led him to a Ph.D. in Biochemistry at the University of Madras, Guindy Campus, where he graduated with high commendation. His doctoral research, centered on luteolin’s protective role in colon cancer, provided deep insights into the modulation of key signaling pathways, including Wnt/β-catenin, angiogenesis, apoptosis, and oxidative stress. This academic foundation prepared him for impactful global research and teaching contributions in oncology.

Experience

Dr. Ashok Kumar Pandurangan has accumulated extensive professional experience in teaching and research, spanning globally recognized institutions. He began his post-doctoral career at the Children’s Hospital Oakland Research Institute where he studied the role of sphingolipid metabolism in colon cancer progression. Later, as a Post-Doctoral Fellow at Universiti Putra Malaysia, he investigated nanomaterials for cancer therapy, bioflavonoids in autophagy, and dietary components like rice bran derivatives for cancer prevention. He then joined the University of Malaya as a Visiting Research Fellow, contributing to cancer pharmacology and drug screening studies. Since, he has been serving as an Associate Professor at B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, where he teaches biochemistry and life sciences while actively pursuing funded research projects. His diverse experience across continents reflects a blend of academic leadership, translational research, and innovative problem-solving in cancer therapeutics.

Research Focus

Dr. Ashok Kumar Pandurangan’s research focuses on cancer biology, molecular signaling, and translational therapeutics. His primary areas of investigation include signal transduction mechanisms in colon and breast cancers, ulcerative colitis, and colitis-associated cancers. His work emphasizes the chemopreventive and therapeutic potential of natural products, exploring compounds such as luteolin, green tea polyphenols, and rice bran derivatives in both in vitro and in vivo models. His post-doctoral research expanded into nanotechnology, evaluating nanomaterials for cancer therapy and drug delivery. Additionally, he has studied autophagy-mediated cell death in colorectal cancer and the role of sphingolipid metabolism in cancer progression. By targeting pathways like Wnt/β-catenin, Nrf2-ARE, TGF-β/Smad, and apoptotic signaling, his research bridges molecular biology with clinical applications. His multidisciplinary approach integrates biochemistry, pharmacology, and oncology, aiming to develop safe, effective, and innovative therapeutic strategies for cancer treatment and prevention.

Awards and Honors

Dr. Ashok Kumar Pandurangan has earned several recognitions throughout his career for academic excellence and research contributions in cancer biology. His Ph.D. thesis at the University of Madras was rated highlighting the novelty and impact of his work on luteolin in colon carcinogenesis. His achievements include securing prestigious international post-doctoral fellowships in the United States and Malaysia, enabling him to collaborate with leading scientists in oncology. He has received funding and project support for his research on nanomaterials, natural products, and cancer therapeutics. His global research exposure has resulted in numerous publications in reputed international journals, reflecting his scientific contributions to signal transduction, drug screening, and molecular oncology. In addition, he has been recognized for his active participation in international conferences and workshops, where he has presented his findings and built collaborations. These awards and honors underscore his standing as a respected researcher and educator in biochemistry and cancer research.

Publication Top Notes

Conclusion

The researcher demonstrates a strong research profile, with a focus on cancer research and a strong academic background. Their research experience and projects demonstrate their expertise in the field. With further evaluation of their publication record, citation impact, and collaboration, they could become an even stronger candidate for the Excellence in Research. Their contributions to the field of cancer research, and their potential for future research, make them a strong contender for this award.

Marcio Jose Concepcion-Zavaleta | Bio Materials | Young Scientist Award

Dr. Marcio Jose Concepcion-Zavaleta | Bio Materials | Young Scientist Award

Research | Universidad Científica del Sur | Peru

Dr. Marcio Jose Concepcion-Zavaleta is a Peruvian physician and endocrinologist, recognized for his outstanding academic and research achievements. He graduated as the top student at the Universidad Nacional de Trujillo, Faculty of Medicine, excelling throughout six years of medical training. He completed his internship at Hospital Nacional Edgardo Rebagliati Martins in Lima and later pursued residency training in Endocrinology at Hospital Nacional Guillermo Almenara Irigoyen – EsSalud. Currently, he serves as an endocrinologist at Javier Prado Clinic and Hospital Voto Bernales, while actively engaging in academic and clinical research. With more than indexed publications in Scopus, PubMed, and SciELO, he has contributed significantly to the literature on diabetes, thyroid disorders, obesity, and metabolic bone disease. A member of international and national endocrine societies, he also serves on editorial boards of leading journals and mentors young researchers, aiming to advance endocrinology through research and education.

Professional Profile

Orcid

Scholar

Education

Dr. Marcio Jose Concepcion-Zavaleta earned his Doctor of Medicine degree from the Universidad Nacional de Trujillo, Peru, where he consistently ranked first in his cohort of students across all six years of medical school. His excellence in academic performance was further demonstrated during his internship at Hospital Nacional Edgardo Rebagliati Martins, one of Peru’s most prestigious hospitals, where he gained comprehensive clinical experience. Driven by a passion for endocrinology, he pursued specialty training through a residency in Endocrinology at Hospital Nacional Guillermo Almenara Irigoyen – EsSalud in Lima, Peru. This residency provided him with specialized clinical expertise in managing complex endocrine disorders, including diabetes, thyroid disease, and metabolic bone conditions. His education extended beyond clinical practice to research, where he developed strong skills in scientific writing, systematic reviews, and evidence-based medicine. This educational foundation established him as both a skilled clinician and a prolific researcher.

Experience

Dr. Marcio Jose Concepcion-Zavaleta has built a solid career in both clinical endocrinology and academic research. Following his medical degree and residency, he began practicing as a specialist endocrinologist at Javier Prado Clinic and Hospital Voto Bernales in Lima, Peru, where he continues to provide expert care in diabetes, thyroid disorders, obesity, and bone metabolism. Beyond clinical duties, he has actively contributed to academia, serving as an Associate Researcher at Universidad Científica del Sur. His research portfolio includes more than  scientific articles, spanning systematic reviews, narrative reviews, case reports, descriptive studies, and analytical investigations, published in high-quality journals indexed in Scopus, PubMed, and SciELO. He has served as an editorial team member for the World Journal of Gastroenterology (Q1) and the Electronic Journal of General Medicine (Q3), contributing to peer review and editorial processes. He also mentors medical students and residents, emphasizing scientific writing and research methodology.

Research Focus

Dr. Marcio Jose Concepcion-Zavaleta focuses his research on diabetes mellitus, thyroid disorders, obesity, and metabolic bone diseases, with an emphasis on evidence-based medicine and clinical applicability. He has published extensively on the diagnosis, treatment, and management of endocrine disorders, contributing both to the scientific literature and clinical guidelines. His research interests extend to autoimmune thyroid disease and its systemic manifestations, as well as the metabolic complications of obesity and diabetes. He has also engaged in multidisciplinary collaborations, particularly in gastroenterology and internal medicine, reflecting the interconnected nature of chronic diseases. Beyond disease-specific research, he has contributed methodologically through systematic reviews, narrative reviews, and case reports, offering valuable evidence to inform clinical decision-making. His involvement as an editor and peer reviewer further underscores his commitment to ensuring quality in scientific publications. Ultimately, his research aims to bridge clinical practice with academic inquiry, improving patient care outcomes in endocrinology.

Awards and Honors

Dr. Marcio Jose Concepcion-Zavaleta has consistently been recognized for his academic excellence and scientific productivity. His most notable early achievement was graduating as valedictorian of his medical class at the Universidad Nacional de Trujillo, underscoring his academic dedication. His prolific research output, with more than 70 peer-reviewed publications, has earned him a strong reputation nationally and internationally. His active participation as a speaker and contributor in national and international medical conferences highlights his role in knowledge dissemination and professional leadership. He holds memberships in the American Society of Endocrinology and the Peruvian Society of Endocrinology, reflecting his engagement with professional communities. Furthermore, his editorial contributions to the World Journal of Gastroenterology (Q1) and the Electronic Journal of General Medicine (Q3) showcase his recognition by the international scientific community. These accomplishments affirm his status as a dedicated clinician-researcher committed to advancing endocrinology through scholarship, education, and professional collaboration.

Publication Top Notes

Conclusion

The researcher demonstrates a strong research profile, with a focus on endocrinology and a significant publication record. Their commitment to education and training, as well as their editorial experience, are notable strengths. With further development of international collaboration and publication in top-tier journals, they could become an even stronger candidate for the Best Researcher Award. Their contributions to the field of endocrinology and their potential for future research make them a strong contender for this award.

Prof. Shang-You Yang | biocompatibility | Best Researcher Award

Prof. Shang-You Yang | biocompatibility | Best Researcher Award

Professor, University of Kansas School of Medicine, United States

The researcher is a dedicated academic and scientist with expertise in pharmaceutical research and biomaterials. As an international reviewer for several prestigious journals, they have demonstrated their commitment to advancing knowledge in their field.

Profile

scholar

🎓 Education

Although specific educational details are not provided, the researcher’s experience as an international reviewer suggests a strong foundation in pharmaceutical research or a related field. Their expertise in reviewing manuscripts for various journals indicates a high level of academic achievement.

👨‍🔬 Experience

– International Reviewer: Various journals, including Journal of Pharmaceutical Research International, Medicina, Molecular Medicine Reports, Aging and Disease, Bioengineering & Translational Medicine, International Journal of Molecular Sciences, and Polymers (2021-present)- The researcher has reviewed multiple manuscripts for these journals, demonstrating their expertise and commitment to advancing knowledge in their field.

🔍 Research Interest

– *Pharmaceutical Research*: Investigating various aspects of pharmaceuticals, including their development, application, and impact on human health.- *Biomaterials*: Exploring the properties and applications of biomaterials in medical research and development.

Awards and Honors🏆

No specific awards or honors are mentioned in the provided information. However, the researcher’s role as an international reviewer for several prestigious journals is a testament to their expertise and reputation in the field.

📚 Publications 

– Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization 🌟
– Inflammatory responses to orthopaedic biomaterials in the murine air pouch 🔬
– Diverse cellular and apoptotic responses to variant shapes of UHMWPE particles in a murine model of inflammation 💡
– Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells 🏥
– Effect of porosity and pore size on microstructures and mechanical properties of poly-ε-caprolactone-hydroxyapatite composites 🔍
– Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model 💊
– Murine model of prosthesis failure for the long-term study of aseptic loosening 🐭
– A novel murine model of orthopaedic wear-debris associated osteolysis 🔬

Conclusion

S.Y. Yang is a highly accomplished researcher with a strong background in biomaterials and tissue engineering. Their innovative research has contributed significantly to the understanding of complex topics, such as tissue-engineered bone regeneration and orthopedic implant loosening. With their consistent research output and interdisciplinary collaborations, Yang is an excellent candidate for the Best Researcher Award. Their research has the potential to improve human health outcomes, and their dedication to advancing knowledge in their field is evident in their publications.

Assoc. Prof. Dr. Joanna Mystkowska | Biomaterials | Best Researcher Award

Assoc. Prof. Dr. Joanna Mystkowska | Biomaterials | Best Researcher Award

Institute of Biomedical Engineering, Bialystok University of Technology, Poland

The researcher is a distinguished academic and scientist with extensive experience in materials engineering and biomaterials. Currently serving as the Head of the Department of Biomaterials and Medical Devices Engineering at Bialystok University of Technology, they have a strong background in research and education.

Profile

orcid

🎓 Education

– (link unavailable) Degree: Materials Engineering, Warsaw University of Technology (2019)- *Doctor of Technical Sciences*: Materials Engineering, specialty: Biomaterials, Warsaw University of Technology (2008)- *Master of Science*: Enterprise Management, Warsaw University of Technology (2004)- *Master of Science*: Plastics Technology, Warsaw University of Technology (2003)

👨‍🔬 Experience

– *Head of Department*: Biomaterials and Medical Devices Engineering, Bialystok University of Technology (2024-present)- *Associate Professor*: Institute of Biomedical Engineering, Bialystok University of Technology (2019-present)- *Adjunct Lecturer*: Department of Materials Engineering and Production, Bialystok University of Technology (2010-2016)- *Scientific and Teaching Assistant*: Department of Materials and Biomedical Engineering, Bialystok University of Technology (2003-2009)

🔍 Research Interest

– *Polymers and Composites*: Medical applications, degradation processes, and thermal properties- *Biological Fluids*: Modification, physicochemical, biological, rheological, and tribological properties- *Biofilm Investigations*: Surfaces of implant materials

Awards and Honors

– *Academic Award*: Most active employee in Biomedical Engineering discipline (2022)- *Academic Scholarship*: Outstanding young scientists (2014-2017)- *Scholarship*: Young doctors of the Bialystok University of Technology (2010-2011)- *Best Poster Award*: International Conference of the Polish Society of Biomechanics (2012)- *Medal of the National Education Commission* (2012)

📚 Publications 

– Rheological Investigation of Polydimethylsiloxane with Glass Beads: A Model for Compression-Stiffening Effects in Soft Tissue Engineering Materials 🔬
– Influence of Perfluorodecalin Content on the Properties of Blood Substitute 💉
– Mechanical Properties of Inflamed Appendix Tissues 🏥
– Spin-Coating Fabrication Method of PDMS/NdFeB Composites Using Chitosan/PCL Coating 🎨
– Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells 🎯
– Degradation of Polylactide and Polycaprolactone as a Result of Biofilm Formation 🌿
– N-Acetyl-Cysteine Increases Activity of Peanut-Shaped Gold Nanoparticles Against Biofilms 💡

Conclusion

The researcher’s impressive academic background, leadership roles, international experience, and awards make them an excellent candidate for the Best Researcher Award. Their research focus on polymers and composites for medical applications, degradation processes, and biological fluids demonstrates their expertise and potential to make significant contributions to their field. With some potential for interdisciplinary collaborations and industry partnerships, the researcher is well-suited to receive this award.

Selvam Guhanathan | BIOPOLYMERIC MATERIALS | Best Researcher Award

Prof. Dr. Selvam Guhanathan | BIOPOLYMERIC MATERIALS | Best Researcher Award

Professor, MUTHURANGAM GOVERNMENT ARTS COLLEGE, VELLORE, India

Dr. S. Guhanathan is a renowned researcher and academician with expertise in chemistry. He has authored books and laboratory manuals, edited research articles, and served as a resource person in various programs.

Profile

orcid

🎓 Education

Not specified in the provided text, however, his academic credentials and experience suggest a strong background in chemistry.

👨‍🔬 Experience

– Resource person in various programs, including “In-service training program for secondary Grade Science Teachers” and “Mathematical applications of Chemistry” 📚– Editorial member in State level seminar on recent trends in Polymer Chemistry 📝– Editor-in-chief, UGC-sponsored national conference on Frontiers in Spectroscopy (NCOFIS-2012) 🔍

🔍 Research Interest

Dr. Guhanathan’s research focus appears to be in the field of chemistry, with expertise in spectroscopy and polymer chemistry. His work includes editing research articles and serving as a resource person in various programs.

Awards and Honors

No specific awards or honors are mentioned in the provided text, however, his contributions to research and education are notable.

📚 Publications 

1. “A Text book of Engineering Chemistry” 📚
2. “Engineering Chemistry Laboratory Record” 🔬
3. “Instrumental Analysis Laboratory Manual” 🔍
4. Edited 76 research articles for UGC-sponsored national conference on Frontiers in Spectroscopy (NCOFIS-2012)

Conclusion

Based on the provided information, Dr. S. Guhanathan appears to be a strong candidate for the Best Researcher Award, given his expertise sharing, leadership roles, and community engagement. Addressing the areas for improvement could further strengthen his candidacy. His contributions to education and research are notable, and his potential for future impact is significant.